Publications by authors named "M Ziol"

Claim this Profile
T
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab.
Claudia Campani, Clelia Galvanin, Ju Hyun Shim, Mohamed Bouattour, Yann Touchefeu, Marianne Ziol

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.
Jean-Charles Nault, Claudia Campani, Theo Z Hirsch, Ethan Neumann, Waqar Arif, Marianne Ziol

medRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort.
Manon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, Mohamed Bouattour, Julien Edeline, Marianne Ziol

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis.
Pierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, Fabien Zoulim, Thomas Decaens, Marianne Ziol

J Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma.
Lorraine Blaise, Marianne Ziol, Claudia Campani, Nathalie Ganne-Carrie, Pierre Nahon

JHEP Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis